SR-11383

N/A

Report date: 2023/05/22 10:18:16

Base Information

Drug NameSR-11383

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionRetinoic acid receptor beta antagonists

TargetsRetinoic acid receptor beta

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSri International

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSri International

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A